518 related articles for article (PubMed ID: 22967381)
1. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
[TBL] [Abstract][Full Text] [Related]
2. Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation.
Yang J; Li R; Ren Y; Yang Y; Xie R; Fan H
Scand J Immunol; 2013 Dec; 78(6):486-96. PubMed ID: 24283771
[TBL] [Abstract][Full Text] [Related]
3. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
4. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
[TBL] [Abstract][Full Text] [Related]
5. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
6. Rapid lethality of hosts by interleukin-12 following H-2 compatible allogeneic bone marrow transplantation: Reminiscence of gut-associated acute graft-versus-host reaction.
Schmitt M; Taniguchi M; Yoshida T; Miyahara Y; Gu X; Mukai K; Yagita H; Dohner H; Shiku H
Int J Oncol; 2002 Oct; 21(4):795-801. PubMed ID: 12239618
[TBL] [Abstract][Full Text] [Related]
7. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
Ewing P; Miklos S; Olkiewicz KM; Müller G; Andreesen R; Holler E; Cooke KR; Hildebrandt GC
Exp Hematol; 2007 Jan; 35(1):155-63. PubMed ID: 17198884
[TBL] [Abstract][Full Text] [Related]
8. [Effects of immature dendritic cells to express CCR7 on graft-versus-host disease in allogeneic bone marrow transplant mouse model].
Li DP; Wu JQ; Huang YH; Song LX; Gu HH; Gao CL; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):782-7. PubMed ID: 24103877
[TBL] [Abstract][Full Text] [Related]
9. Prevention of murine acute graft-versus-host disease by recipient-derived TGFbeta1-treated dendritic cells.
Mou HB; Lin MF; Cen H; Huang H; Cai Z
Transplant Proc; 2004 Jun; 36(5):1604-6. PubMed ID: 15251394
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Xu J; Wei J; Huang M; Zhu X; Guan J; Yin J; Xiao Y; Zhang Y
Int Immunopharmacol; 2013 Nov; 17(3):601-7. PubMed ID: 23993943
[TBL] [Abstract][Full Text] [Related]
11. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
12. [Transforming growth factor beta alleviates acute graft-versus-host-disease after allogeneic bone marrow transplantation in murine model].
Wang YN; Feng CC; Liu JL; Li F; Fu L; Wang Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1135-9. PubMed ID: 18928612
[TBL] [Abstract][Full Text] [Related]
13. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation].
Wang CL; Xu KL; Pan XY; Du B
Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308
[TBL] [Abstract][Full Text] [Related]
14. [Blockage of Th17 cells differentiation exacerbated mouse acute intestine graft-versus-host disease following allogeneic bone marrow transplantation].
Li HJ; Cheng H; Pan B; Zeng LY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):1024-7. PubMed ID: 23363796
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-10 Gene-Modified Dendritic Cell-Induced Type 1 Regulatory T Cells Induce Transplant-Tolerance and Impede Graft Versus Host Disease After Allogeneic Stem Cell Transplantation.
Wan J; Huang F; Hao S; Hu W; Liu C; Zhang W; Deng X; Chen L; Ma L; Tao R
Cell Physiol Biochem; 2017; 43(1):353-366. PubMed ID: 28869950
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of transforming growth factor-beta1 and transforming growth factor-beta1 type II receptor genes are associated with acute graft-versus-host disease in children with HLA-matched sibling bone marrow transplantation.
Hattori H; Matsuzaki A; Suminoe A; Ihara K; Nagatoshi Y; Sakata N; Kawa K; Okamura J; Hara T
Bone Marrow Transplant; 2002 Nov; 30(10):665-71. PubMed ID: 12420205
[TBL] [Abstract][Full Text] [Related]
20. Predominant immature CD8alpha+ dendritic cells prevent graft-vs.-host disease but do not increase the risk of leukemia recurrence.
Xu L; Duan L; Cao K; Yuan G; Peng Y; Huang X; Xiang P; Li S
Eur J Haematol; 2007 Mar; 78(3):235-45. PubMed ID: 17253973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
